Parsons Capital Management Inc. RI Sells 24,241 Shares of Re

Parsons Capital Management Inc. RI reduced its stake in Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 949,841 shares of the company’s stock after selling 24,241 shares during […]

Related Keywords

Maged Shenouda , Nasdaq , Blackrock Inc , Parsons Capital Management Inc , Relmada Therapeutics Inc , Renaissance Technologies , Exchange Commission , Millennium Management , Parsons Capital Management , Relmada Therapeutics , Free Report , Capital Management , Alto Investors , Sigma Investments , Chuck Ence , Relmada Therapeutics Daily , Nasdaq Rlmd , Rlmd , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,